source
- Fierce Biotech flags five cities poised to become next biotech powerhousesFierce Biotech’s latest special report identifies five cities that could emerge as major biotech hubs. The podcast episode of “The Top Line” highlights Boston, San Francisco, Beijing, Seattle and C…
- Eli Lilly to buy psychedelics biotech AtaiBeckley for $2.8 billion, adding late-stage depression drugEli Lilly announced it will acquire New York‑based biotech AtaiBeckley in a transaction valued at about $2.8 billion. The agreement sets the purchase price at $6.75 per share, a 26 % premium to At…